vs
安道拓(ADNT)与艾伯维(ARGX)财务数据对比。点击上方公司名可切换其他公司
安道拓的季度营收约是艾伯维的1.5倍($3.6B vs $2.5B),艾伯维净利率更高(35.5% vs -0.6%,领先36.1%),艾伯维同比增速更快(83.2% vs 4.3%),艾伯维自由现金流更多($322.4M vs $15.0M)
安道拓是全球规模最大的汽车座椅制造商,注册地位于爱尔兰,运营总部设在美国密歇根州普利茅斯,业务覆盖全球各地,为全球客户提供专业的汽车座椅相关产品及解决方案,在汽车座椅领域拥有领先的市场地位与技术优势。
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业,研发生产的药物覆盖多种疾病治疗领域,可满足多元临床需求,致力于为全球不同病症的患者提供可靠的治疗方案选择。
ADNT vs ARGX — 直观对比
营收规模更大
ADNT
是对方的1.5倍
$2.5B
营收增速更快
ARGX
高出78.9%
4.3%
净利率更高
ARGX
高出36.1%
-0.6%
自由现金流更多
ARGX
多$307.4M
$15.0M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $3.6B | $2.5B |
| 净利润 | $-22.0M | $877.2M |
| 毛利率 | 6.0% | 89.5% |
| 营业利润率 | 1.1% | 28.9% |
| 净利率 | -0.6% | 35.5% |
| 营收同比 | 4.3% | 83.2% |
| 净利润同比 | — | 1.3% |
| 每股收益(稀释后) | $-0.28 | $13.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ADNT
ARGX
| Q4 25 | $3.6B | $2.5B | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.7B | $1.8B | ||
| Q1 25 | $3.6B | — | ||
| Q4 24 | $3.5B | $1.4B | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.7B | $901.9M | ||
| Q1 24 | $3.8B | — |
净利润
ADNT
ARGX
| Q4 25 | $-22.0M | $877.2M | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $36.0M | $414.8M | ||
| Q1 25 | $-335.0M | — | ||
| Q4 24 | $0 | $865.6M | ||
| Q3 24 | $79.0M | — | ||
| Q2 24 | $-11.0M | $-32.5M | ||
| Q1 24 | $-70.0M | — |
毛利率
ADNT
ARGX
| Q4 25 | 6.0% | 89.5% | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 6.3% | 89.2% | ||
| Q1 25 | 7.2% | — | ||
| Q4 24 | 6.2% | 90.2% | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 5.6% | 89.4% | ||
| Q1 24 | 6.1% | — |
营业利润率
ADNT
ARGX
| Q4 25 | 1.1% | 28.9% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.8% | 19.2% | ||
| Q1 25 | -7.3% | — | ||
| Q4 24 | 1.3% | 8.7% | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 1.2% | -15.4% | ||
| Q1 24 | -1.1% | — |
净利率
ADNT
ARGX
| Q4 25 | -0.6% | 35.5% | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.0% | 23.4% | ||
| Q1 25 | -9.3% | — | ||
| Q4 24 | — | 64.1% | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | -0.3% | -3.6% | ||
| Q1 24 | -1.9% | — |
每股收益(稀释后)
ADNT
ARGX
| Q4 25 | $-0.28 | $13.25 | ||
| Q3 25 | $0.17 | — | ||
| Q2 25 | $0.43 | $6.32 | ||
| Q1 25 | $-3.99 | — | ||
| Q4 24 | $0.00 | $13.33 | ||
| Q3 24 | $0.88 | — | ||
| Q2 24 | $-0.12 | $-0.55 | ||
| Q1 24 | $-0.77 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $3.5B |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.7B | $7.3B |
| 总资产 | $8.8B | $8.7B |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势,按日历期对齐
现金及短期投资
ADNT
ARGX
| Q4 25 | — | $3.5B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | — |
总债务
ADNT
ARGX
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | $11.0M | ||
| Q1 24 | $2.4B | — |
股东权益
ADNT
ARGX
| Q4 25 | $1.7B | $7.3B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | $6.1B | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.9B | $5.5B | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $1.9B | $4.3B | ||
| Q1 24 | $2.1B | — |
总资产
ADNT
ARGX
| Q4 25 | $8.8B | $8.7B | ||
| Q3 25 | $9.0B | — | ||
| Q2 25 | $8.8B | $7.2B | ||
| Q1 25 | $8.6B | — | ||
| Q4 24 | $8.5B | $6.2B | ||
| Q3 24 | $9.4B | — | ||
| Q2 24 | $9.1B | $4.8B | ||
| Q1 24 | $9.3B | — |
负债/权益比
ADNT
ARGX
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.28× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.24× | 0.00× | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $80.0M | $323.3M |
| 自由现金流经营现金流 - 资本支出 | $15.0M | $322.4M |
| 自由现金流率自由现金流/营收 | 0.4% | 13.0% |
| 资本支出强度资本支出/营收 | 1.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.37× |
| 过去12个月自由现金流最近4个季度 | $174.0M | $594.5M |
8季度趋势,按日历期对齐
经营现金流
ADNT
ARGX
| Q4 25 | $80.0M | $323.3M | ||
| Q3 25 | $213.0M | — | ||
| Q2 25 | $172.0M | $361.8M | ||
| Q1 25 | $-45.0M | — | ||
| Q4 24 | $109.0M | $41.9M | ||
| Q3 24 | $263.0M | — | ||
| Q2 24 | $158.0M | $-124.7M | ||
| Q1 24 | $81.0M | — |
自由现金流
ADNT
ARGX
| Q4 25 | $15.0M | $322.4M | ||
| Q3 25 | $134.0M | — | ||
| Q2 25 | $115.0M | $356.6M | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $45.0M | $40.9M | ||
| Q3 24 | $191.0M | — | ||
| Q2 24 | $88.0M | $-125.5M | ||
| Q1 24 | $12.0M | — |
自由现金流率
ADNT
ARGX
| Q4 25 | 0.4% | 13.0% | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 3.1% | 20.1% | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 1.3% | 3.0% | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 2.4% | -13.9% | ||
| Q1 24 | 0.3% | — |
资本支出强度
ADNT
ARGX
| Q4 25 | 1.8% | 0.0% | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.5% | 0.3% | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.8% | 0.1% | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.9% | 0.1% | ||
| Q1 24 | 1.8% | — |
现金转化率
ADNT
ARGX
| Q4 25 | — | 0.37× | ||
| Q3 25 | 11.83× | — | ||
| Q2 25 | 4.78× | 0.87× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | 3.33× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图